PP

Poli Pally Prashanth Kumar

Active Director Director DIN 09047881
DIN 09047881 First appointment Feb 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Poli Pally Prashanth Kumar

Data last updated:

Poli Pally Prashanth Kumar is a Director at Kavel Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals.

DIN 09047881
Primary Designation Director
Industry Chemicals
First Appointment 01 Feb 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Feb 20212021Active

Board colleagues of Poli Pally Prashanth Kumar

NameDINCompanyDesignation
Satyanarayana Alamakanne09047880Kavel Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kavel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Poli Pally Prashanth Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poli Pally Prashanth Kumar

Poli Pally Prashanth Kumar currently holds 1 directorship: Kavel Pharmaceuticals Private Limited (Director, since 01 Feb 2021).

Poli Pally Prashanth Kumar was first appointed on 01 Feb 2021 as Director at Kavel Pharmaceuticals Private Limited.

The current boards of Poli Pally Prashanth Kumar's companies include Satyanarayana Alamakanne (Kavel Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available